Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001013762-25-002767
Filing Date
2025-03-26
Accepted
2025-03-26 16:52:58
Documents
4

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea0235557-424b5_jasper.htm 424B5 125787
2 GRAPHIC image_001.jpg GRAPHIC 4563
3 GRAPHIC image_002.jpg GRAPHIC 26093
4 GRAPHIC image_003.jpg GRAPHIC 4286
  Complete submission text file 0001013762-25-002767.txt   175457
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

EIN.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-285914 | Film No.: 25773968
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)